

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 7.19425967 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 6.97688368 |
| 3 | retinal cone cell development (GO:0046549) | 6.09081040 |
| 4 | photoreceptor cell maintenance (GO:0045494) | 5.24638583 |
| 5 | photoreceptor cell development (GO:0042461) | 5.06902624 |
| 6 | eye photoreceptor cell development (GO:0042462) | 4.93251757 |
| 7 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.79742960 |
| 8 | detection of light stimulus involved in visual perception (GO:0050908) | 4.79742960 |
| 9 | protein localization to synapse (GO:0035418) | 4.65873427 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.63820980 |
| 11 | gamma-aminobutyric acid transport (GO:0015812) | 4.60833111 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.56558864 |
| 13 | behavioral response to nicotine (GO:0035095) | 4.48493607 |
| 14 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.44204890 |
| 15 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.29911492 |
| 16 | retinal rod cell development (GO:0046548) | 4.26390446 |
| 17 | auditory behavior (GO:0031223) | 4.05723760 |
| 18 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.97866053 |
| 19 | phototransduction (GO:0007602) | 3.95446937 |
| 20 | vocalization behavior (GO:0071625) | 3.87984017 |
| 21 | detection of light stimulus (GO:0009583) | 3.86402963 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.86010955 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.84213753 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.81579399 |
| 25 | protein-chromophore linkage (GO:0018298) | 3.80228337 |
| 26 | detection of visible light (GO:0009584) | 3.79637436 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.79070423 |
| 28 | nucleobase catabolic process (GO:0046113) | 3.76599390 |
| 29 | phototransduction, visible light (GO:0007603) | 3.74962274 |
| 30 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.74617798 |
| 31 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.71257922 |
| 32 | visual perception (GO:0007601) | 3.67479649 |
| 33 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.67200239 |
| 34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.66538752 |
| 35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.65325786 |
| 36 | sensory perception of light stimulus (GO:0050953) | 3.65049075 |
| 37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.62230349 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.59611364 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 3.59486487 |
| 40 | eye photoreceptor cell differentiation (GO:0001754) | 3.58190938 |
| 41 | photoreceptor cell differentiation (GO:0046530) | 3.58190938 |
| 42 | startle response (GO:0001964) | 3.57224273 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.55085197 |
| 44 | mechanosensory behavior (GO:0007638) | 3.53438942 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.53165467 |
| 46 | epithelial cilium movement (GO:0003351) | 3.53041079 |
| 47 | protein localization to cilium (GO:0061512) | 3.52835838 |
| 48 | glutamate receptor signaling pathway (GO:0007215) | 3.47127464 |
| 49 | long-term memory (GO:0007616) | 3.46246220 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.45168748 |
| 51 | positive regulation of neurotransmitter transport (GO:0051590) | 3.44002383 |
| 52 | presynaptic membrane assembly (GO:0097105) | 3.43762191 |
| 53 | nonmotile primary cilium assembly (GO:0035058) | 3.40976414 |
| 54 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.39807571 |
| 55 | response to histamine (GO:0034776) | 3.39404145 |
| 56 | primary amino compound metabolic process (GO:1901160) | 3.37886257 |
| 57 | positive regulation of action potential (GO:0045760) | 3.34865340 |
| 58 | neuronal action potential (GO:0019228) | 3.34707420 |
| 59 | regulation of guanylate cyclase activity (GO:0031282) | 3.33528808 |
| 60 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.33504582 |
| 61 | membrane hyperpolarization (GO:0060081) | 3.31856562 |
| 62 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.31100421 |
| 63 | glutamate secretion (GO:0014047) | 3.29962914 |
| 64 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28596255 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.26891374 |
| 66 | serotonin metabolic process (GO:0042428) | 3.24962896 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24588352 |
| 68 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.21187785 |
| 69 | neuronal action potential propagation (GO:0019227) | 3.20569810 |
| 70 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.19405393 |
| 71 | membrane depolarization during action potential (GO:0086010) | 3.19398424 |
| 72 | axonal fasciculation (GO:0007413) | 3.18187991 |
| 73 | protein polyglutamylation (GO:0018095) | 3.16860528 |
| 74 | axoneme assembly (GO:0035082) | 3.15665254 |
| 75 | behavioral response to cocaine (GO:0048148) | 3.14736547 |
| 76 | synaptic vesicle maturation (GO:0016188) | 3.14558727 |
| 77 | postsynaptic membrane organization (GO:0001941) | 3.14057671 |
| 78 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13383449 |
| 79 | synaptic transmission, dopaminergic (GO:0001963) | 3.12013504 |
| 80 | regulation of synaptic vesicle transport (GO:1902803) | 3.09718445 |
| 81 | presynaptic membrane organization (GO:0097090) | 3.08750647 |
| 82 | righting reflex (GO:0060013) | 3.07702007 |
| 83 | behavioral fear response (GO:0001662) | 3.06376576 |
| 84 | behavioral defense response (GO:0002209) | 3.06376576 |
| 85 | response to auditory stimulus (GO:0010996) | 3.04006930 |
| 86 | striatum development (GO:0021756) | 3.03891313 |
| 87 | detection of abiotic stimulus (GO:0009582) | 3.03531098 |
| 88 | GMP metabolic process (GO:0046037) | 3.03387184 |
| 89 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.01984194 |
| 90 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.00970622 |
| 91 | regulation of neurotransmitter secretion (GO:0046928) | 3.00416340 |
| 92 | locomotory exploration behavior (GO:0035641) | 2.98281509 |
| 93 | response to pheromone (GO:0019236) | 2.98255195 |
| 94 | detection of external stimulus (GO:0009581) | 2.97130486 |
| 95 | proline transport (GO:0015824) | 2.96830691 |
| 96 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.95244368 |
| 97 | synapse assembly (GO:0007416) | 2.95167025 |
| 98 | cAMP catabolic process (GO:0006198) | 2.94597002 |
| 99 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.94091630 |
| 100 | adult walking behavior (GO:0007628) | 2.93191020 |
| 101 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92723390 |
| 102 | behavioral response to ethanol (GO:0048149) | 2.91708704 |
| 103 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.91656620 |
| 104 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.91656620 |
| 105 | neuron recognition (GO:0008038) | 2.90398115 |
| 106 | fear response (GO:0042596) | 2.90103733 |
| 107 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.90018579 |
| 108 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.89696695 |
| 109 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.89045025 |
| 110 | C4-dicarboxylate transport (GO:0015740) | 2.88867758 |
| 111 | synaptic vesicle endocytosis (GO:0048488) | 2.88519834 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88061389 |
| 113 | retinal ganglion cell axon guidance (GO:0031290) | 2.85703133 |
| 114 | axonemal dynein complex assembly (GO:0070286) | 2.85468220 |
| 115 | fucose catabolic process (GO:0019317) | 2.85347441 |
| 116 | L-fucose metabolic process (GO:0042354) | 2.85347441 |
| 117 | L-fucose catabolic process (GO:0042355) | 2.85347441 |
| 118 | cilium movement (GO:0003341) | 2.84585388 |
| 119 | central nervous system myelination (GO:0022010) | 2.84419295 |
| 120 | axon ensheathment in central nervous system (GO:0032291) | 2.84419295 |
| 121 | cilium organization (GO:0044782) | 2.83711903 |
| 122 | long-term synaptic potentiation (GO:0060291) | 2.83563252 |
| 123 | female mating behavior (GO:0060180) | 2.82059004 |
| 124 | reflex (GO:0060004) | 2.81950263 |
| 125 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.81776240 |
| 126 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80096929 |
| 127 | inner ear receptor stereocilium organization (GO:0060122) | 2.79980045 |
| 128 | cilium assembly (GO:0042384) | 2.79883792 |
| 129 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.78327598 |
| 130 | cilium morphogenesis (GO:0060271) | 2.76995026 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 2.76253992 |
| 132 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 2.76221642 |
| 133 | neural tube formation (GO:0001841) | 2.75981354 |
| 134 | central nervous system neuron axonogenesis (GO:0021955) | 2.75792088 |
| 135 | neurotransmitter transport (GO:0006836) | 2.75696302 |
| 136 | regulation of synapse maturation (GO:0090128) | 2.74834491 |
| 137 | transmission of nerve impulse (GO:0019226) | 2.74629141 |
| 138 | spinal cord development (GO:0021510) | 2.74376968 |
| 139 | neurotransmitter secretion (GO:0007269) | 2.74345219 |
| 140 | intraciliary transport (GO:0042073) | 2.73452756 |
| 141 | retina layer formation (GO:0010842) | 2.72572588 |
| 142 | glycosphingolipid biosynthetic process (GO:0006688) | 2.68868933 |
| 143 | positive regulation of synapse assembly (GO:0051965) | 2.68218919 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 2.67733091 |
| 145 | adult behavior (GO:0030534) | 2.67376318 |
| 146 | neuromuscular synaptic transmission (GO:0007274) | 2.66828365 |
| 147 | indolalkylamine metabolic process (GO:0006586) | 2.65348388 |
| 148 | regulation of action potential (GO:0098900) | 2.58233547 |
| 149 | regulation of neurotransmitter levels (GO:0001505) | 2.57173586 |
| 150 | regulation of synapse structural plasticity (GO:0051823) | 2.56453225 |
| 151 | membrane depolarization (GO:0051899) | 2.56360333 |
| 152 | hindbrain development (GO:0030902) | 2.56289459 |
| 153 | synaptic transmission, cholinergic (GO:0007271) | 2.52729488 |
| 154 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.52132450 |
| 155 | tryptophan catabolic process (GO:0006569) | 2.51833898 |
| 156 | indole-containing compound catabolic process (GO:0042436) | 2.51833898 |
| 157 | indolalkylamine catabolic process (GO:0046218) | 2.51833898 |
| 158 | regulation of respiratory system process (GO:0044065) | 2.51824847 |
| 159 | regulation of neurotransmitter uptake (GO:0051580) | 2.51358722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28813307 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.27313511 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.70874070 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66720720 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64307884 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.60910106 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.55018481 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32068983 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31455502 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.30131020 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29957372 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28687759 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18506584 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16448940 |
| 15 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.16271840 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.15167551 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15001526 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15001526 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09733011 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.06317890 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04721373 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04304633 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01917380 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98659576 |
| 25 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.97274004 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.95065582 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93962096 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.89685147 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89590848 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89542678 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84881952 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.83935769 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83739381 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80717198 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78699078 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78190788 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76634215 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74469916 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74300427 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69696343 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69089922 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64695688 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.62880719 |
| 44 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60699418 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55630887 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55204935 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53460583 |
| 48 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52261782 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49796564 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.49655749 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.49013311 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48573457 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47789995 |
| 54 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.47095176 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45308987 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45278165 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45278165 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44880204 |
| 59 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.44680808 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.40548107 |
| 61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.40503420 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39692985 |
| 63 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.38435903 |
| 64 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.38269445 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38268204 |
| 66 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36456922 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36125090 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32614873 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32238388 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31465849 |
| 71 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.30725258 |
| 72 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.28532722 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27931156 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27640562 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.27483369 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.25564053 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24739573 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24547617 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23343745 |
| 80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.23020102 |
| 81 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.22143192 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20842226 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20624118 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20615714 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20503580 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20444269 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20263235 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20081127 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20080613 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19219203 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18809699 |
| 92 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.18646456 |
| 93 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18088002 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16368040 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16091286 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14972084 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14972084 |
| 98 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14031697 |
| 99 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13783252 |
| 100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13000243 |
| 101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12979263 |
| 102 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12217249 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 1.12057540 |
| 104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11312846 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10794455 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10774216 |
| 107 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10419676 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09744622 |
| 109 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09669705 |
| 110 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08285002 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08256150 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07950133 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07915790 |
| 114 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07502909 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05764155 |
| 116 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.05239198 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.05119836 |
| 118 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04947759 |
| 119 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.04169592 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03565129 |
| 121 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03039082 |
| 122 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02435535 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01295633 |
| 124 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01295633 |
| 125 | JUN_21703547_ChIP-Seq_K562_Human | 1.01271870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 4.76940264 |
| 2 | MP0003880_abnormal_central_pattern | 4.19912258 |
| 3 | MP0003011_delayed_dark_adaptation | 3.83195421 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.61211138 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.16975672 |
| 6 | MP0005253_abnormal_eye_physiology | 3.13892317 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 3.07769757 |
| 8 | MP0001188_hyperpigmentation | 2.93379014 |
| 9 | MP0003635_abnormal_synaptic_transmissio | 2.80479438 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.71193409 |
| 11 | MP0009745_abnormal_behavioral_response | 2.67437556 |
| 12 | MP0004270_analgesia | 2.57349352 |
| 13 | MP0001486_abnormal_startle_reflex | 2.52758363 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.39257520 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.36028922 |
| 16 | MP0002822_catalepsy | 2.32303100 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.29989149 |
| 18 | MP0001984_abnormal_olfaction | 2.29327688 |
| 19 | MP0009046_muscle_twitch | 2.23914437 |
| 20 | MP0002064_seizures | 2.22498679 |
| 21 | MP0002272_abnormal_nervous_system | 2.20335533 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.19920460 |
| 23 | MP0002735_abnormal_chemical_nociception | 2.17512776 |
| 24 | MP0010386_abnormal_urinary_bladder | 2.17496330 |
| 25 | MP0001986_abnormal_taste_sensitivity | 2.14889782 |
| 26 | MP0006276_abnormal_autonomic_nervous | 2.04772343 |
| 27 | MP0002736_abnormal_nociception_after | 2.01617873 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.00817763 |
| 29 | MP0006292_abnormal_olfactory_placode | 2.00121387 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.81583800 |
| 31 | MP0005195_abnormal_posterior_eye | 1.80677504 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.72799586 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.72349194 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.66499645 |
| 35 | MP0003121_genomic_imprinting | 1.65289863 |
| 36 | MP0003787_abnormal_imprinting | 1.64396263 |
| 37 | MP0002229_neurodegeneration | 1.62368466 |
| 38 | MP0002752_abnormal_somatic_nervous | 1.62023783 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.60467409 |
| 40 | MP0002102_abnormal_ear_morphology | 1.57701689 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.55536959 |
| 42 | MP0001529_abnormal_vocalization | 1.55361899 |
| 43 | MP0001970_abnormal_pain_threshold | 1.55329682 |
| 44 | MP0005499_abnormal_olfactory_system | 1.52844828 |
| 45 | MP0005394_taste/olfaction_phenotype | 1.52844828 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.52627308 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.51865645 |
| 48 | MP0004133_heterotaxia | 1.48989531 |
| 49 | MP0002184_abnormal_innervation | 1.48386477 |
| 50 | MP0008004_abnormal_stomach_pH | 1.43969249 |
| 51 | MP0004924_abnormal_behavior | 1.41681739 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.41681739 |
| 53 | MP0000778_abnormal_nervous_system | 1.41411290 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.39854718 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.37329384 |
| 56 | MP0005409_darkened_coat_color | 1.36502545 |
| 57 | MP0003283_abnormal_digestive_organ | 1.32626458 |
| 58 | MP0003136_yellow_coat_color | 1.31350592 |
| 59 | MP0001905_abnormal_dopamine_level | 1.30435793 |
| 60 | MP0001324_abnormal_eye_pigmentation | 1.27021807 |
| 61 | MP0004742_abnormal_vestibular_system | 1.26119272 |
| 62 | MP0005391_vision/eye_phenotype | 1.25864770 |
| 63 | MP0000427_abnormal_hair_cycle | 1.21663034 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.20653573 |
| 65 | MP0008789_abnormal_olfactory_epithelium | 1.20314330 |
| 66 | MP0002090_abnormal_vision | 1.19422064 |
| 67 | MP0004142_abnormal_muscle_tone | 1.13943253 |
| 68 | MP0003879_abnormal_hair_cell | 1.13543052 |
| 69 | MP0004043_abnormal_pH_regulation | 1.13026199 |
| 70 | MP0000026_abnormal_inner_ear | 1.11772997 |
| 71 | MP0003950_abnormal_plasma_membrane | 1.10911878 |
| 72 | MP0005187_abnormal_penis_morphology | 1.10732240 |
| 73 | MP0002837_dystrophic_cardiac_calcinosis | 1.10585475 |
| 74 | MP0008569_lethality_at_weaning | 1.10387923 |
| 75 | MP0003195_calcinosis | 1.09748557 |
| 76 | MP0004147_increased_porphyrin_level | 1.07911750 |
| 77 | MP0002751_abnormal_autonomic_nervous | 1.03422771 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.00523756 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.00225544 |
| 80 | MP0000955_abnormal_spinal_cord | 0.98289770 |
| 81 | MP0004885_abnormal_endolymph | 0.97625354 |
| 82 | MP0002938_white_spotting | 0.96303127 |
| 83 | MP0004811_abnormal_neuron_physiology | 0.93001290 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 0.91664207 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.89346517 |
| 86 | MP0002160_abnormal_reproductive_system | 0.85808560 |
| 87 | MP0003119_abnormal_digestive_system | 0.83896089 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.82027810 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79757275 |
| 90 | MP0008872_abnormal_physiological_respon | 0.77758840 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.77167321 |
| 92 | MP0002152_abnormal_brain_morphology | 0.76977968 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.76796936 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.76382965 |
| 95 | MP0003861_abnormal_nervous_system | 0.76374073 |
| 96 | MP0000566_synostosis | 0.75350074 |
| 97 | MP0005389_reproductive_system_phenotype | 0.75311192 |
| 98 | MP0008995_early_reproductive_senescence | 0.74802103 |
| 99 | MP0005410_abnormal_fertilization | 0.74353456 |
| 100 | MP0005379_endocrine/exocrine_gland_phen | 0.70149736 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.69599685 |
| 102 | MP0003633_abnormal_nervous_system | 0.67809059 |
| 103 | MP0005171_absent_coat_pigmentation | 0.67792852 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.66231414 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.64928871 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.64217655 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.63535045 |
| 108 | MP0001664_abnormal_digestion | 0.62809680 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.62424347 |
| 110 | MP0001177_atelectasis | 0.60717787 |
| 111 | MP0003634_abnormal_glial_cell | 0.59232885 |
| 112 | MP0003122_maternal_imprinting | 0.57130845 |
| 113 | MP0002928_abnormal_bile_duct | 0.56963208 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.56871140 |
| 115 | MP0003045_fibrosis | 0.56593768 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.55708015 |
| 117 | MP0003698_abnormal_male_reproductive | 0.54976681 |
| 118 | MP0003631_nervous_system_phenotype | 0.53837461 |
| 119 | MP0004484_altered_response_of | 0.52324175 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.51247024 |
| 121 | MP0008877_abnormal_DNA_methylation | 0.50594179 |
| 122 | MP0003938_abnormal_ear_development | 0.50128460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.51872206 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.73428796 |
| 3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.23061406 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.14125188 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 5.07786166 |
| 6 | Dyschromatopsia (HP:0007641) | 5.00731299 |
| 7 | Attenuation of retinal blood vessels (HP:0007843) | 4.88012706 |
| 8 | Central scotoma (HP:0000603) | 4.75339838 |
| 9 | Decreased central vision (HP:0007663) | 4.74904074 |
| 10 | Focal motor seizures (HP:0011153) | 4.73716393 |
| 11 | Chorioretinal atrophy (HP:0000533) | 4.44010217 |
| 12 | Pendular nystagmus (HP:0012043) | 4.42197081 |
| 13 | Pigmentary retinal degeneration (HP:0001146) | 4.26567314 |
| 14 | Febrile seizures (HP:0002373) | 4.13934250 |
| 15 | Scotoma (HP:0000575) | 4.05982898 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 4.01024841 |
| 17 | Gait imbalance (HP:0002141) | 3.85435588 |
| 18 | Severe visual impairment (HP:0001141) | 3.77866602 |
| 19 | Medial flaring of the eyebrow (HP:0010747) | 3.77523988 |
| 20 | Congenital primary aphakia (HP:0007707) | 3.70910212 |
| 21 | Abnormal ciliary motility (HP:0012262) | 3.65993366 |
| 22 | Epileptic encephalopathy (HP:0200134) | 3.59670826 |
| 23 | Photophobia (HP:0000613) | 3.52816594 |
| 24 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.47109881 |
| 25 | Absent/shortened dynein arms (HP:0200106) | 3.47109881 |
| 26 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.46285191 |
| 27 | Nephrogenic diabetes insipidus (HP:0009806) | 3.44843834 |
| 28 | Increased corneal curvature (HP:0100692) | 3.43619992 |
| 29 | Keratoconus (HP:0000563) | 3.43619992 |
| 30 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.42707179 |
| 31 | Retinitis pigmentosa (HP:0000510) | 3.28914737 |
| 32 | Type II diabetes mellitus (HP:0005978) | 3.20293853 |
| 33 | Myokymia (HP:0002411) | 3.18281542 |
| 34 | Focal seizures (HP:0007359) | 3.04336843 |
| 35 | True hermaphroditism (HP:0010459) | 2.98027678 |
| 36 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.96663102 |
| 37 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.96663102 |
| 38 | Type II lissencephaly (HP:0007260) | 2.95144105 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94278170 |
| 40 | Choroideremia (HP:0001139) | 2.89662237 |
| 41 | Hemiparesis (HP:0001269) | 2.83870080 |
| 42 | Limb dystonia (HP:0002451) | 2.79439162 |
| 43 | Poor coordination (HP:0002370) | 2.76175783 |
| 44 | Vaginal atresia (HP:0000148) | 2.71870316 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.69651616 |
| 46 | Genital tract atresia (HP:0001827) | 2.67112147 |
| 47 | Drooling (HP:0002307) | 2.63904780 |
| 48 | Lissencephaly (HP:0001339) | 2.62571178 |
| 49 | Macular degeneration (HP:0000608) | 2.61162605 |
| 50 | Cone-rod dystrophy (HP:0000548) | 2.59479846 |
| 51 | Abnormality of the renal cortex (HP:0011035) | 2.55418661 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.54797929 |
| 53 | Constricted visual fields (HP:0001133) | 2.53340171 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.49195546 |
| 55 | Polydipsia (HP:0001959) | 2.49195546 |
| 56 | Pancreatic cysts (HP:0001737) | 2.38935996 |
| 57 | Broad-based gait (HP:0002136) | 2.38146207 |
| 58 | Excessive salivation (HP:0003781) | 2.37863295 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.36422706 |
| 60 | Optic disc pallor (HP:0000543) | 2.35646944 |
| 61 | Tubular atrophy (HP:0000092) | 2.33888082 |
| 62 | Gaze-evoked nystagmus (HP:0000640) | 2.33257702 |
| 63 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.31886442 |
| 64 | Polyphagia (HP:0002591) | 2.30455628 |
| 65 | Hypothermia (HP:0002045) | 2.25709397 |
| 66 | Hyperventilation (HP:0002883) | 2.21822774 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.21347441 |
| 68 | Sclerocornea (HP:0000647) | 2.16834374 |
| 69 | Pachygyria (HP:0001302) | 2.14797272 |
| 70 | Cerebellar dysplasia (HP:0007033) | 2.13986322 |
| 71 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13628152 |
| 72 | Atonic seizures (HP:0010819) | 2.12630994 |
| 73 | Nephronophthisis (HP:0000090) | 2.11897621 |
| 74 | Vitreoretinal degeneration (HP:0000655) | 2.11645140 |
| 75 | Hypsarrhythmia (HP:0002521) | 2.11587682 |
| 76 | Dysdiadochokinesis (HP:0002075) | 2.10586212 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 2.10496519 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 2.10496519 |
| 79 | Bile duct proliferation (HP:0001408) | 2.09883229 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 2.09883229 |
| 81 | Visual hallucinations (HP:0002367) | 2.09505767 |
| 82 | Anencephaly (HP:0002323) | 2.08666294 |
| 83 | Action tremor (HP:0002345) | 2.08099844 |
| 84 | Occipital encephalocele (HP:0002085) | 2.07667250 |
| 85 | Tubulointerstitial nephritis (HP:0001970) | 2.06956089 |
| 86 | Optic nerve hypoplasia (HP:0000609) | 2.04766156 |
| 87 | Rhinitis (HP:0012384) | 2.04103282 |
| 88 | Generalized tonic-clonic seizures (HP:0002069) | 2.02781595 |
| 89 | Agitation (HP:0000713) | 2.00875373 |
| 90 | Specific learning disability (HP:0001328) | 1.99522853 |
| 91 | Cystic liver disease (HP:0006706) | 1.99464389 |
| 92 | Absence seizures (HP:0002121) | 1.99111568 |
| 93 | Progressive inability to walk (HP:0002505) | 1.96183098 |
| 94 | Abnormality of the labia minora (HP:0012880) | 1.95180226 |
| 95 | Dialeptic seizures (HP:0011146) | 1.93196262 |
| 96 | Fetal akinesia sequence (HP:0001989) | 1.92376851 |
| 97 | Status epilepticus (HP:0002133) | 1.90914124 |
| 98 | Intestinal atresia (HP:0011100) | 1.89390548 |
| 99 | Male pseudohermaphroditism (HP:0000037) | 1.89229878 |
| 100 | Posterior subcapsular cataract (HP:0007787) | 1.87675314 |
| 101 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86905534 |
| 102 | Genetic anticipation (HP:0003743) | 1.86470273 |
| 103 | Polyuria (HP:0000103) | 1.86414866 |
| 104 | Truncal ataxia (HP:0002078) | 1.84432159 |
| 105 | Large for gestational age (HP:0001520) | 1.84370973 |
| 106 | Furrowed tongue (HP:0000221) | 1.82539106 |
| 107 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.80790213 |
| 108 | Chronic hepatic failure (HP:0100626) | 1.79155135 |
| 109 | Narrow forehead (HP:0000341) | 1.77718419 |
| 110 | Abnormal eating behavior (HP:0100738) | 1.77640530 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.76310073 |
| 112 | Astigmatism (HP:0000483) | 1.73701147 |
| 113 | Abnormal EKG (HP:0003115) | 1.72870238 |
| 114 | Renal cortical cysts (HP:0000803) | 1.72835072 |
| 115 | Hemiplegia (HP:0002301) | 1.71755733 |
| 116 | Protruding tongue (HP:0010808) | 1.71325656 |
| 117 | Postaxial hand polydactyly (HP:0001162) | 1.70893646 |
| 118 | Congenital hepatic fibrosis (HP:0002612) | 1.70152799 |
| 119 | Postaxial foot polydactyly (HP:0001830) | 1.70139898 |
| 120 | Abnormality of the renal medulla (HP:0100957) | 1.69445623 |
| 121 | Abnormal hair whorl (HP:0010721) | 1.68888890 |
| 122 | Amblyopia (HP:0000646) | 1.68370198 |
| 123 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.66761999 |
| 124 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.66761999 |
| 125 | Dyskinesia (HP:0100660) | 1.66345148 |
| 126 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.65724205 |
| 127 | Absent speech (HP:0001344) | 1.64262728 |
| 128 | Hypoplasia of the fovea (HP:0007750) | 1.61898900 |
| 129 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.61898900 |
| 130 | Inability to walk (HP:0002540) | 1.61078171 |
| 131 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.60830655 |
| 132 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.59963279 |
| 133 | Prolonged QT interval (HP:0001657) | 1.59425324 |
| 134 | Chorioretinal coloboma (HP:0000567) | 1.56438998 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 1.56010059 |
| 136 | Anxiety (HP:0000739) | 1.55923297 |
| 137 | Septo-optic dysplasia (HP:0100842) | 1.55709791 |
| 138 | Retinal dysplasia (HP:0007973) | 1.55409366 |
| 139 | Ventricular fibrillation (HP:0001663) | 1.54637419 |
| 140 | Fair hair (HP:0002286) | 1.54350699 |
| 141 | Poor eye contact (HP:0000817) | 1.53995405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.33626470 |
| 2 | EPHA4 | 3.95512328 |
| 3 | CASK | 3.87787642 |
| 4 | NTRK3 | 3.77457067 |
| 5 | GRK1 | 3.49303008 |
| 6 | TNIK | 3.25245257 |
| 7 | MAP2K7 | 2.89377088 |
| 8 | MARK1 | 2.46508942 |
| 9 | STK16 | 2.42216674 |
| 10 | MAP4K2 | 2.35790817 |
| 11 | RIPK4 | 2.15595299 |
| 12 | MAP3K4 | 2.11466244 |
| 13 | BMPR2 | 1.99941451 |
| 14 | MAP3K12 | 1.96721897 |
| 15 | MAPK13 | 1.80324757 |
| 16 | ADRBK2 | 1.72774728 |
| 17 | PBK | 1.70036682 |
| 18 | NTRK2 | 1.65220903 |
| 19 | DAPK2 | 1.63162652 |
| 20 | PINK1 | 1.52321240 |
| 21 | MINK1 | 1.44008115 |
| 22 | WNK4 | 1.43631876 |
| 23 | DYRK2 | 1.39280791 |
| 24 | TRIM28 | 1.36680342 |
| 25 | CSNK1G2 | 1.35030628 |
| 26 | PRPF4B | 1.34352902 |
| 27 | STK38 | 1.31894037 |
| 28 | CDK19 | 1.29050866 |
| 29 | PLK2 | 1.28577899 |
| 30 | NUAK1 | 1.28256358 |
| 31 | MUSK | 1.27921235 |
| 32 | IRAK2 | 1.23407456 |
| 33 | SIK2 | 1.23392784 |
| 34 | PNCK | 1.22239983 |
| 35 | ACVR1B | 1.15632928 |
| 36 | CAMK2A | 1.15422928 |
| 37 | MAP3K9 | 1.12953251 |
| 38 | OXSR1 | 1.11868162 |
| 39 | SGK2 | 1.11149588 |
| 40 | MAP2K4 | 1.11120151 |
| 41 | PRKCG | 1.10995124 |
| 42 | PAK3 | 1.10657692 |
| 43 | FES | 1.08984866 |
| 44 | GRK5 | 1.07498058 |
| 45 | CDK5 | 1.06916615 |
| 46 | NEK6 | 1.06910181 |
| 47 | FGFR2 | 1.06864863 |
| 48 | CSNK1G3 | 1.05485667 |
| 49 | SGK494 | 1.03891914 |
| 50 | SGK223 | 1.03891914 |
| 51 | TNK2 | 1.02447648 |
| 52 | AKT3 | 1.02043481 |
| 53 | MKNK2 | 1.01639802 |
| 54 | CDK3 | 0.99033692 |
| 55 | MAPK15 | 0.97478419 |
| 56 | PAK6 | 0.97369767 |
| 57 | CSNK1G1 | 0.96805276 |
| 58 | CCNB1 | 0.93537397 |
| 59 | CAMK2B | 0.92212425 |
| 60 | BCR | 0.90248348 |
| 61 | CSNK1A1L | 0.89376615 |
| 62 | PRKCE | 0.87596988 |
| 63 | PIK3CG | 0.86424044 |
| 64 | DYRK1A | 0.83685587 |
| 65 | CAMK1 | 0.83166690 |
| 66 | INSRR | 0.82759618 |
| 67 | CAMK2D | 0.79746321 |
| 68 | CAMKK1 | 0.79742668 |
| 69 | DAPK1 | 0.79351403 |
| 70 | SIK3 | 0.78658820 |
| 71 | WNK3 | 0.77514166 |
| 72 | SGK1 | 0.76547062 |
| 73 | NTRK1 | 0.76213380 |
| 74 | ZAK | 0.75697757 |
| 75 | PKN1 | 0.74534569 |
| 76 | TLK1 | 0.74156029 |
| 77 | NME1 | 0.73822719 |
| 78 | DYRK3 | 0.70380464 |
| 79 | TXK | 0.68820503 |
| 80 | CDC42BPA | 0.68034988 |
| 81 | EPHB2 | 0.66701706 |
| 82 | IRAK3 | 0.63615449 |
| 83 | STK38L | 0.62533749 |
| 84 | PHKG2 | 0.61872103 |
| 85 | PHKG1 | 0.61872103 |
| 86 | KSR1 | 0.61699260 |
| 87 | ADRBK1 | 0.61302531 |
| 88 | STK11 | 0.61048761 |
| 89 | MAP3K13 | 0.60658794 |
| 90 | BCKDK | 0.60285145 |
| 91 | LMTK2 | 0.59693334 |
| 92 | CAMK4 | 0.55486421 |
| 93 | PIK3CA | 0.55167356 |
| 94 | PRKD3 | 0.54105708 |
| 95 | TGFBR1 | 0.53599194 |
| 96 | CAMK2G | 0.53131690 |
| 97 | TAOK3 | 0.51172240 |
| 98 | ERBB3 | 0.51033884 |
| 99 | PRKACA | 0.50878941 |
| 100 | EIF2AK2 | 0.50170710 |
| 101 | SGK3 | 0.49786607 |
| 102 | PRKCH | 0.48830857 |
| 103 | MAPKAPK5 | 0.48750019 |
| 104 | STK39 | 0.48737547 |
| 105 | UHMK1 | 0.46817456 |
| 106 | ERBB2 | 0.45949475 |
| 107 | MARK2 | 0.45903564 |
| 108 | PLK4 | 0.45785230 |
| 109 | MAPK7 | 0.45513477 |
| 110 | CSNK1A1 | 0.44712176 |
| 111 | GRK7 | 0.44532605 |
| 112 | VRK1 | 0.44444111 |
| 113 | PRKCB | 0.43374280 |
| 114 | PRKCZ | 0.43313038 |
| 115 | IRAK1 | 0.41881006 |
| 116 | RPS6KA5 | 0.41857548 |
| 117 | EPHA3 | 0.41765237 |
| 118 | CDK18 | 0.41720093 |
| 119 | MKNK1 | 0.41520717 |
| 120 | BRD4 | 0.40948842 |
| 121 | ARAF | 0.40948532 |
| 122 | CSNK1D | 0.40654292 |
| 123 | CAMKK2 | 0.40650710 |
| 124 | PTK2B | 0.40327927 |
| 125 | PRKCA | 0.40073813 |
| 126 | PRKD2 | 0.38788354 |
| 127 | BMPR1B | 0.38667148 |
| 128 | TIE1 | 0.38633691 |
| 129 | MAPK12 | 0.38593164 |
| 130 | BRAF | 0.38447756 |
| 131 | PRKG1 | 0.37328788 |
| 132 | PRKAA1 | 0.36764464 |
| 133 | FGR | 0.36563734 |
| 134 | TSSK6 | 0.34616732 |
| 135 | RPS6KA4 | 0.32803716 |
| 136 | RPS6KA3 | 0.31281436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 8.68880356 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50889553 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.19078485 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.73608567 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.70780486 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.69041022 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56487846 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48179468 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34798733 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34421216 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32612584 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.08943495 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.95360875 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90352308 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86998635 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.81445944 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81318827 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80032621 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.78351494 |
| 20 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.69819682 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.68436918 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51031954 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50444444 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.47850086 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.47657723 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.47272901 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40996525 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.40426469 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36302481 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35756150 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33516567 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29580665 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26972246 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.21826390 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18413937 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17981737 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16785336 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16766131 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08899336 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.06884296 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05054973 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04769498 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03314372 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02328996 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02226845 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99334033 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98543835 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98344881 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98143090 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97179995 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95098738 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92711319 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90429347 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88419436 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86994278 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.86856304 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84301487 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.83836889 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81592181 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79507312 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76838211 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76462855 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73451739 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73127365 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.71406493 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71213506 |
| 67 | Gap junction_Homo sapiens_hsa04540 | 0.70749463 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70665078 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69835141 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64141173 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64107234 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64084506 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63391925 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63335498 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.62907261 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.62370874 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62333009 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62300409 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61629234 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61252220 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61179957 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57367845 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.55109243 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54181693 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52765594 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52153977 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51827667 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51661458 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50991729 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50629473 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48760842 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.48740694 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48528651 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48119942 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47546990 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47154368 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45825167 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.43859178 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43645771 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42006832 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40005158 |
| 102 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39840223 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39710830 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39358270 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38399136 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38385895 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37994630 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36313171 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36062059 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36053225 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34776440 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33938186 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33814061 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33486014 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33439094 |
| 116 | Bile secretion_Homo sapiens_hsa04976 | 0.33115274 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32846061 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31815101 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31002575 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30096606 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29667849 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29512346 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29478694 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28020777 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.27342872 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26626144 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24266301 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24210171 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.21757561 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.21667185 |
| 131 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18983464 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.17951336 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16255552 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16047495 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.15617721 |

